上海荣泰健康科技股份有限公司关于使用可转债闲置募集资金进行现金管理的公告

Core Viewpoint - The company plans to utilize idle funds from convertible bonds for cash management, aiming to enhance the efficiency of fund usage and generate financial returns for shareholders [2][4][12]. Investment Overview - Investment Purpose: The company intends to manage idle funds from convertible bonds without affecting the safety and intended use of the raised funds, thereby maximizing financial returns [4]. - Investment Amount: The amount allocated for cash management is RMB 100 million [4]. - Funding Source: The funds for this investment come from idle proceeds of the convertible bonds, which were approved by the China Securities Regulatory Commission and raised a total of RMB 600 million [5]. Investment Details - Investment Type: The company will invest in low-risk financial products with high liquidity [2][11]. - Investment Method: The cash management does not involve structured arrangements and does not constitute related-party transactions [8]. Recent Developments - The company has made changes to the use of some convertible bond proceeds, reducing the investment scale of the original project and postponing its timeline, while introducing new projects [6][7]. - As of September 30, 2025, the original project had a progress rate of 25.54%, and the new projects have not yet utilized the raised funds [7]. Impact on the Company - The cash management initiative is expected to improve investment returns and fund usage efficiency without impacting the company's main business operations or the progress of investment projects [12]. - The amount of RMB 100 million allocated for cash management is not expected to significantly affect the company's future operations, financial status, or cash flow [12]. Regulatory Compliance - The company has followed necessary approval procedures for the cash management initiative, ensuring compliance with relevant regulations and maintaining the integrity of the investment projects [12].